Daniel A. Holterman

Programmed Cell Death 1 (PD-1) and Its Ligand (PD-L1) in Common Cancers and Their Correlation with Molecular Cancer Type

Zoran Gatalica, Carrie Snyder, Todd Maney et al. · Cancer Epidemiology Biomarkers & Prevention · 2014 · 526 citations

Medicine, Immunology, Oncology +17

Overexpression of α-defensin is associated with bladder cancer invasiveness

Daniel A. Holterman, José I. Diaz, P F Blackmore et al. · Urologic Oncology Seminars and Original Investigations · 2006 · 49 citations

Medicine, Cancer Biology, Oncology +5

Orthotopic treatment model of prostate cancer and metastasis in the immunocompetent mouse: Efficacy of flt3 ligand immunotherapy

Kenneth D. Somers, Roy R. Brown, Daniel A. Holterman et al. · International Journal of Cancer · 2003 · 34 citations

Medicine, Oncology, Urology +17

Barrett Esophagus With Dysplasia:<i>Flow Cytometric DNA Analysis of Routine, Paraffin-Embedded Mucosal Biopsies</i>

Elizabeth A. Montgomery, Dan-Paul Hartmann, Norman J. Carr et al. · American Journal of Clinical Pathology · 1996 · 34 citations

Medicine, Oncology, Pathology +12

Preclinical and clinical studies on immunogenicity and safety of the HIV-1 p17-based synthetic peptide AIDS vaccine — HGP-30-KLH

Paul H. Naylor, Marcelo B. Sztein, Saiji Wada et al. · International Journal of Immunopharmacology · 1991 · 31 citations

Life Sciences, Immunology, Infectious Diseases +12